Clinical Trial Update: Patient Reported Outcomes in Adults With Pediatric-onset Hypophosphatasia Treated With Strensiq® (Asfotase Alfa)

View source ↗

Summary

A completed clinical trial update examining patient-reported outcomes in adults with pediatric-onset hypophosphatasia treated with Strensiq (asfotase alfa).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypophosphatasia

Drugs mentioned

• STRENSIQ (asfotase alfa)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Hypophosphatasia | Status: COMPLETED